Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5987502 | The Journal of Thoracic and Cardiovascular Surgery | 2016 | 9 Pages |
Abstract
Metformin exposure in diabetic patients with early-stage non-small cell lung cancer may be associated with improved progression-free survival, but no effect was seen on overall survival. Further studies are warranted to evaluate if there is a therapeutic role for metformin in the treatment of non-small cell lung cancer.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Robert A. BS, James MS, Simon DO, John C. MD, Ravi MD, Fatima MD, Gary W. MD, William H. MD, Sanjib PhD, Jeffrey A. PhD, Michael J. MD, Christopher W. MD,